ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis
S. Cotte(Hertie Foundation), Andrew Chan(Infosys (India)), Jan Dörr(Charité - Universitätsmedizin Berlin), Nikolaus König, Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Uwe K. Zettl(University of Rostock), Friedemann Paul(Max Delbrück Center), Ralf Gold(University Hospitals of the Ruhr-University of Bochum), Hermann Koepsell(University of Würzburg), Alexander Winkelmann(University of Rostock), N. Téllez(Universitat Autònoma de Barcelona), Frauke Zipp(Johannes Gutenberg University Mainz), Brian E. Huber(Hertie Foundation), Nicolas von Ahsen(University of Göttingen), M. Starck, Niels Kruse(Universitätsmedizin Göttingen), H. W. Pannek(Evangelisches Krankenhaus Bielefeld), Fred Lühder(Universitätsmedizin Göttingen)
Cited by 74
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k